APUS (Apimeds Pharmaceuticals, Inc.) Net earnings per share (EPS TTM)

Apimeds (APUS) - corporate logo

Apimeds Pharmaceuticals (APUS) brings together experts in autoimmune pathologies, providing scientists with academic freedom. The business's venture success relies on FDA approval of bee venom-based drugs. The company creates natural alternatives to hormones for arthritis therapy. Analyzing this chart of the net income per share YoY ttm growth rate from GURU.Markets, it is evident that the parameter has stabilized at -1060.70.

Apimeds - APUS Earnings per share for the last twelve months (period 11/23/2025 - 11/16/2026)

APUS (Apimeds): analytical breakdowns and indicator data

Fundamental company valuation:APUS Apimeds Pharmaceuticals
Flagship merchandise of Apimeds Pharmaceuticals, Inc.

EPS TTM dynamics measure the percentage change in earnings per share over the last twelve months, allowing for an assessment of fundamental growth momentum and capitalization efficiency. Analyzing the current YoY TTM growth in net income per share helps determine the extent to which the implementation of laboratory robotics and molecule screening automation at Apimeds Pharmaceuticals (APUS) is translating into actual financial results.

Direct competitors

Net earnings per one share for the last twelve months Jazz Pharma|CYTK (Cytokinetics Inc.) - Net earnings per share for the last 12 months|PTC Bio (PTCT) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Scholar Rock|CNTA: Earnings per share for the trailing year|Earnings per share for the last twelve months Dyne Therapeutics (DYN)|EWTX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Rapport Pharma RAPP|Alumis Pharma - Earnings per share for the last twelve months|ZVRA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Contineum Therapeutics, Inc.|LRMR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Capricor Therapeutics CAPR|Net earnings per share for the last 12 months TRDA|Net earnings per one share for the last twelve months Channel PTHS|Earnings per share for the last twelve months MediciNova Inc. (MNOV)|SER - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BTAI (BioXcel Therapeutics Inc)|ProMIS Neurosciences (PMN) - Net earnings per one share for the last twelve months|AEON - Earnings per share for the last twelve months|Net earnings per share for the last four quarters NLS Pharmaceutics Ltd. NLSP|Bionomics Limited (BNOX) - Earnings per share for the last twelve months|fsdpharma.com - Earnings per share for the trailing year|RETA (reatapharma.com) - Net earnings per share (EPS TTM)